NR3C2 and hydrops fetalis: The current clinical management of pediatric HF includes the use of angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, diuretics, aldosterone receptor antagonists, digoxin, and anticoagulants, all of which are based on adult HF clinical studies (3).